Product Code: RP-ID-10346895 |
Published Date: 21 Oct 2022 |
Region: NA |
Category: Healthcare & Pharmaceuticals |
Report ID: 10346895
Market Overview:
Global Albumin & Creatinine Tests Market Size study, by Product (Analyzers, Cartridges (PoC, Tabletop), Dipsticks Kits, Reagents), by Type (Blood & Urine Creatinine, Urine Albumin, Glycated Albumin), by End-User (Hospital, Diagnostic & Research Labs), and Regional Forecasts 2020-2027
Global Albumin & Creatinine Tests Market is valued at approximately USD 0.84 billion in 2019 and is anticipated to grow with a healthy growth rate of more than 16.8 % over the forecast period 2020-2027. A small amount of a protein called albumin, collectively known as microalbumin. Normally, it is present in the blood. Creatinine is contained in urine as a normal waste product. The creatinine ratio of a microalbumin compares the amount of albumin to the amount of creatinine in the urine. The growing prevalence of kidney disorders/diseases, the increasing acceptance of POC (Point of Care) diagnostics, and the increasing prevalence of chronic conditions are driving the growth of the global market for albumin & creatinine testing. One of the main causes of death in the world is kidney failure. These cases involving multiple kidney therapies involve routine monitoring of components such as creatinine and albumin and their ratios, for which different products and techniques of urine analysis are used. In the diagnosis and treatment of kidney diseases, urine analysis has wide applications. Analysis of biochemical urine helps physicians to measure the level in the urine of chemical compounds (such as creatinine, urobilinogen, bilirubin, ketones, and glucose). In 2018, U.S. Arkray and Beckman Coulter announced a collaboration and launch of the iQ Urinalysis Workcell, which pairs the Iris iQ200 Digital Flow Morphology system from Beckman with the fully automated urine analyzer Arkray Aution Max AX-4030. Similarly, Abbott Laboratories (US) is a prominent player throughout all the regions in albumin and creatinine tests market. For example, the firm acquired Alere Inc. in 2017 to join the overall market for urine analysis. A number of testing kits and measurement kits are offered by the company. With this purchase, Abbott is expected to play an important role in the overall market for urine analysis and therefore in the market for albumin and creatinine research. However, the market faces restraints because of semi-automated machines or manual review are still favored by most of small hospitals and clinics with lower workloads. Large hospitals with higher workloads mainly use automated devices; therefore, the generation of revenue will justify the costs incurred in installing automated analyzers. This makes it difficult for automated analyzers, especially in developed economies, to reach the market.
The regional analysis of the global Albumin & Creatinine Tests Market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America, and Rest of the World. Asia Pacific is the leading/significant region across the world in terms of Market share owing to the growth in demand for rapid urine tests. Whereas Asia Pacific is also anticipated to exhibit the highest growth rate / CAGR over the forecast period 2020-2027, Owing to increasing prevalence of chronic conditions leading to various kidney diseases and rising government initiatives
Major Market player included in this report are:
Thermo Fisher Scientific, Inc.
Roche Diagnostics
PromoCell GmbH
Abbott Laboratories
Siemens Healthineers
Danaher Corporation
Sysmex Corporation
Ortho Clinical Diagnostics
Randox Laboratories
FUJIFILM Wako Pure Chemical Corporation
The objective of the study is to define Market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the Market. Additionally, the report shall also incorporate available opportunities in micro-Markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the Market are explained below:
By Product:
Analyzers
Cartridges (PoC, Tabletop)
Dipsticks Kits
Reagents
By Type:
Blood & Urine Creatinine
Urine Albumin
Glycated Albumin
By End-User Industry:
Hospital
Diagnostic & Research Labs
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year – 2017, 2018
Base year – 2019
Forecast period – 2020 to 2027.
Target Audience of the Global Albumin & Creatinine Tests Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
Thermo Fisher Scientific, Inc.
Roche Diagnostics
PromoCell GmbH
Abbott Laboratories
Siemens Healthineers
Danaher Corporation
Sysmex Corporation
Ortho Clinical Diagnostics
Randox Laboratories
FUJIFILM Wako Pure Chemical Corporation
Related Reports
Proof of Quality & Reliability
